193 related articles for article (PubMed ID: 10593354)
41. Drugs for Parkinson's disease.
Cranwell-Bruce LA
Medsurg Nurs; 2010; 19(6):347-9, 355; quiz 350. PubMed ID: 21337993
[No Abstract] [Full Text] [Related]
42. Levodopa/carbidopa/entacapone in Parkinson's disease.
Seeberger LC; Hauser RA
Expert Rev Neurother; 2009 Jul; 9(7):929-40. PubMed ID: 19589043
[TBL] [Abstract][Full Text] [Related]
43. Parkinson's disease: managing symptoms and preserving function.
Sweeney PJ
Geriatrics; 1995 Sep; 50(9):24-31. PubMed ID: 7672615
[TBL] [Abstract][Full Text] [Related]
44. [Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?].
Ceballos-Baumann A
MMW Fortschr Med; 2003 May; 145 Suppl 2():99-102. PubMed ID: 14579497
[TBL] [Abstract][Full Text] [Related]
45. Catechol-O-methyltransferase inhibitors: new options for Parkinson's disease.
Leicht MJ; Mitchell SD
S D J Med; 1999 Aug; 52(8):295-7. PubMed ID: 10453205
[No Abstract] [Full Text] [Related]
46. COMT inhibition in Parkinson's disease: rationale and clinical relevance.
Deleu D
Acta Neurol Belg; 2000 Mar; 100(1):5-7. PubMed ID: 10779856
[No Abstract] [Full Text] [Related]
47. Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia.
Sampaio C; Ferreira JJ
Nat Rev Neurol; 2010 Nov; 6(11):590-1. PubMed ID: 21048799
[No Abstract] [Full Text] [Related]
48. Pharmacotherapy for Parkinson's disease.
Chen JJ; Swope DM
Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
[TBL] [Abstract][Full Text] [Related]
49. Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
Simonson W; Hauser RA; Schapira AH
Ann Pharmacother; 2007 Nov; 41(11):1842-9. PubMed ID: 17878397
[TBL] [Abstract][Full Text] [Related]
50. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
Olanow CW; Kieburtz K; Stern M; Watts R; Langston JW; Guarnieri M; Hubble J;
Arch Neurol; 2004 Oct; 61(10):1563-8. PubMed ID: 15477510
[TBL] [Abstract][Full Text] [Related]
51. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.
Danisi F
Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548
[TBL] [Abstract][Full Text] [Related]
52. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
[No Abstract] [Full Text] [Related]
53. [Initial treatment of Parkinson's disease].
Kulisevsky J; López-Villegas D
Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
[TBL] [Abstract][Full Text] [Related]
54. Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients.
Roberts JW; Cora-Locatelli G; Bravi D; Amantea MA; Mouradian MM; Chase TN
Neurology; 1993 Dec; 43(12):2685-8. PubMed ID: 8255478
[TBL] [Abstract][Full Text] [Related]
55. Highlights of the North American and European experiences.
Goetz CG
Neurology; 1998 May; 50(5 Suppl 5):S15-6. PubMed ID: 9591517
[TBL] [Abstract][Full Text] [Related]
56. Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegiline.
Davis TL; Roznoski M; Burns RS
Mov Disord; 1995 May; 10(3):349-51. PubMed ID: 7651456
[TBL] [Abstract][Full Text] [Related]
57. Controversies in the treatment of Parkinson's disease.
Hely MA; Morris JG
Curr Opin Neurol; 1996 Aug; 9(4):308-13. PubMed ID: 8858190
[TBL] [Abstract][Full Text] [Related]
58. The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations.
Stocchi F
Expert Opin Pharmacother; 2006 Jul; 7(10):1399-407. PubMed ID: 16805724
[TBL] [Abstract][Full Text] [Related]
59. Parkinson's disease: medical treatment of moderate to advanced disease.
Suchowersky O
Curr Neurol Neurosci Rep; 2002 Jul; 2(4):310-6. PubMed ID: 12044250
[TBL] [Abstract][Full Text] [Related]
60. Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline.
Davis TL; Roznoski M; Burns RS
Clin Neuropharmacol; 1995 Aug; 18(4):333-7. PubMed ID: 8665546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
